Jove
Visualize
Contact Us

Related Experiment Videos

A feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation.

P J Boyne1, R E Marx, M Nevins

  • 1Department of Oral and Maxillofacial Surgery, School of Dentistry, Loma Linda University, California, USA.

The International Journal of Periodontics & Restorative Dentistry
|February 1, 1997
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world use of second-generation integrase strand transfer inhibitors (INSTI) as switch therapy in the prospective ANRS-CO3-AquiVIH-NA cohort.

HIV medicine·2026
Same author

Thrombosis with thrombocytopenia syndrome following adenovirus vector-based vaccines to prevent COVID-19: Epidemiology and clinical presentation in Spain.

Neurologia·2024
Same author

Characteristics of large granular lymphocyte leukemia associated with variable common immunodeficiency disorders: A study of 12 cases.

European journal of haematology·2024
Same author

[Effect of on patient safety of bedside handoff performed in intensive care units. Systematic review].

Anales del sistema sanitario de Navarra·2022
Same author

Isolated CNS Sarcoidosis Versus Systemic Sarcoidosis With CNS Involvement: A Same Disease?

The Neurohospitalist·2022
Same author

A descriptive study of IgG4-related disease in children and young adults.

Autoimmunity reviews·2022
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Human recombinant bone morphogenetic protein-2 on an absorbable collagen sponge (rhBMP-2/ACS) shows promising results for maxillary sinus floor augmentation. This study found significant bone growth and good safety in patients needing dental implants.

Area of Science:

  • Oral and Maxillofacial Surgery
  • Regenerative Medicine
  • Biomaterials Science

Background:

  • Maxillary sinus floor augmentation is crucial for dental implant success in patients with insufficient bone height.
  • Traditional bone grafting methods have limitations, including donor site morbidity and limited bone availability.
  • Novel biomaterials are needed to improve bone regeneration for dental implantology.

Purpose of the Study:

  • To evaluate the safety and technical feasibility of using human recombinant bone morphogenetic protein-2 delivered on an absorbable collagen sponge (rhBMP-2/ACS) for maxillary sinus floor augmentation.
  • To assess the efficacy of rhBMP-2/ACS in promoting bone growth for dental implant placement.
  • To compare rhBMP-2/ACS with traditional bone graft materials.

Main Methods:

Related Experiment Videos

  • A 16-week, open-label study involving 12 patients with inadequate posterior maxillary bone height.
  • rhBMP-2/ACS was implanted for two-stage maxillary sinus floor augmentation, with doses ranging from 1.77 to 3.40 mg.
  • Computerized tomographic scans, histologic examination of bone biopsies, and clinical follow-up were used to assess outcomes.

Main Results:

  • Significant bone growth was observed in 11 out of 12 patients, with a mean height increase of 8.51 mm.
  • The rhBMP-2/ACS device was easy to handle, and no serious immunologic or adverse effects were reported.
  • Histologic analysis confirmed good bone quality, suitable for dental implant placement.

Conclusions:

  • rhBMP-2/ACS appears to be a safe and technically feasible option for maxillary sinus floor augmentation.
  • This biomaterial demonstrates potential as an alternative to traditional bone grafts for enhancing bone volume in the posterior maxilla.
  • Further research and long-term follow-up are ongoing for patients receiving dental implants.